comparemela.com

Page 7 - Fda Approval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation System

/PRNewswire/ Boston Scientific Corporation (NYSE: BSX) announced it has received U.S. Food and Drug Administration (FDA) approval for the FARAPULSE™ Pulsed.

New yorkUnited statesNick spadea anelloVivek reddyLauren tenglerSteve baileyPrnewswire boston scientific corporationRadiological healthBoston scientific corporationDrug administrationSecurities exchangeExchange commissionSoftware moduleBoston scientificScientific corporationPulsed field ablation

FDA Approves Dupilumab to Treat EoE for Children Under 12 Years

The expanded indication makes dupilumab the only approved treatment for eosinophilic esophagitis (EoE) in this age group.

United statesDupilumab dupixentGeorged yancopoulosNaimish patelHead of global developmentPediatric eoeSymptom questionnaire caregiverGlobal developmentAmerican journalEosinophilic esophagitisFda approval

FDA clears Dupixent to treat esophageal condition in kids under 12

FDA approves Dupixent for pediatric patients with chronic eosinophilic esophagitis, expanding treatment options for children as young as 1 year old.

Naimish patelPediatric patientsHronic eosinophilic esophagitisFda approvalImmune system diseaseUnmet needsPthe fda

MDS Research Expands Treatment Options Across Disease Subsets

Talha Badar, MBBS, MD, discusses myelodysplastic syndrome risk stratification and the FDA approval of luspatercept for patients with this disease.

United statesTalha badarInternational prognostic scoring systemMayo clinicRevised international prognostic scoring systemMyeloproliferative neoplasmsFda approval

European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma s Treatment for Sanfilippo Syndrome (Type A)

/PRNewswire/ GC Biopharma Corp. (006280.KS) announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to its.

South koreaYelin junRachel kimSohee kimEuropean medicines agencyGc biopharma corpPrnewswire gc biopharma corpGreen cross corporationOrphan drug designationEnzyme replacement therapySanfilippo syndromeRare pediatric diseaseNovel pharmaGc biopharmaHealth care amp hospitalsMedical pharmaceuticals

vimarsana © 2020. All Rights Reserved.